Press Releases

Aethlon Medical To Host Third Quarter Fiscal 2017 Investor Call On February 10, 2017

Researchers Announce Plans for Study of Candidate Blood Test to Detect Chronic Traumatic Encephalopathy (CTE) in Former NFL Players

CEO Note - Clinical Study Update and a Review of 2016 Accomplishments

Passage of the 21st Century Cures Act and its Potential Implications on Biodefense

Aethlon Announces Initiation of Sepsis-Related Virus Study

Aethlon Medical Announces Fiscal 2017 Second Quarter Results

Aethlon Medical To Host Second Quarter Fiscal 2017 Investor Call On November 10, 2016

Aethlon Medical Achieves DARPA Milestones, Including Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Validation

Aethlon Medical Announces Corporate Update Presentation At Next Week's 2016 Bio Investor Forum

Aethlon Medical Updates Corporate Presentation Schedule